Identifying Potent Compounds Using Pairwise Consensus Methods.

Area of Science:

• Computational chemistry
• Drug discovery and development
• Structural biology

Background:

• In silico compound screening relies heavily on molecular docking, but traditional consensus strategies are vulnerable to false positives due to scoring function limitations.
• Improving the accuracy of molecular docking is crucial for identifying high-affinity binders from large chemical libraries.
• G protein-coupled receptors (GPCRs) are critical therapeutic targets, necessitating efficient screening methods.

Purpose of the Study:

• To introduce the Pairwise Consensus Score (PCS) algorithm, a novel method to enhance molecular docking accuracy by integrating structural similarity.
• To develop and validate a consensus docking protocol using PCS for targeting GPCRs.
• To identify novel, highly potent antagonism ligands for the neurokinin 1 receptor (NK1).

Main Methods:

• Developed the Pairwise Consensus Score (PCS) algorithm, which evaluates predicted conformations by integrating structural similarity and penalizing dissimilar poses.
• Implemented a consensus docking protocol for G protein-coupled receptors (GPCRs) utilizing the PCS algorithm.
• Screened a large compound library against the neurokinin 1 receptor (NK1) to identify potent antagonism ligands.

Main Results:

• The PCS algorithm effectively integrates structural similarity information to improve the evaluation of docked poses, overcoming limitations of traditional scoring functions.
• A consensus docking protocol using PCS successfully identified several highly potent antagonism ligands for the neurokinin 1 receptor (NK1), exhibiting ten-picomolar activity.
• The newly identified NK1 binders possess chemical structures distinct from previously reported ligands, offering novel pharmacological profiles.

Conclusions:

• The Pairwise Consensus Score (PCS) algorithm represents a significant advancement in molecular docking for drug discovery, enhancing accuracy and reducing false positives.
• The developed PCS-based consensus docking protocol is versatile and effective for targeting GPCRs, as demonstrated by the identification of novel NK1 ligands.
• This study opens new avenues for developing drugs with unique therapeutic properties by discovering compounds with alternative chemical structures and pharmacological features.